Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

41.40
+0.56091.37%
Volume:25.03K
Turnover:1.04M
Market Cap:1.07B
PE:- -
High:41.42
Open:41.13
Low:41.13
Close:40.83
52wk High:42.87
52wk Low:27.30
Shares:25.75M
Float Shares:25.75M
Volume Ratio:1.08
T/O Rate:0.10%
Dividend:0.42
Dividend Rate:1.02%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Bloomsbury Publishing (BMY) Gets a Buy from Berenberg Bank

TIPRANKS
·
16 mins ago

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)

TIPRANKS
·
22 mins ago

Bristol Myers Squibb to Report Q3 Results, Host Earnings Call

Reuters
·
54 mins ago

Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026

THOMSON REUTERS
·
54 mins ago

Merck Says EU CHMP Backs Keytruda-Padcev Perioperative Use in Resectable Muscle-Invasive Bladder Cancer

Reuters
·
57 mins ago

Merck & Co - Final Ec Decision Expected by Q4 2026

THOMSON REUTERS
·
58 mins ago

Merck Receives Positive EU Chmp Opinion for Keytruda® (Pembrolizumab) Plus Padcev® (Enfortumab Vedotin-Ejfv) as Perioperative Treatment for Adults with Resectable Muscle-Invasive Bladder Cancer (Mibc)

THOMSON REUTERS
·
58 mins ago

Merck Launches Your Hive of Whole Health to Support Whole Person Care for People Living with Hiv

THOMSON REUTERS
·
1 hour ago

US Plans Medicaid Most-Favored-Nation Pricing for Some Drugs in All States, Semafor Reports

Reuters
·
2 hours ago

When Weight Loss Isn't the Goal of Taking a GLP-1

Dow Jones
·
10 hours ago

Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
14 hours ago

Bristol-Myers Squibb Announces R$ 2.15-Per-Unit Dividend for Q4 2026

Reuters
·
14 hours ago

Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
15 hours ago

PepsiCo Adds Johnson & Johnson CEO Joaquin Duato to Board, Names Him to Audit Committee

Reuters
·
15 hours ago

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
15 hours ago

Moderna: Another Day, Another Big Stock Move. is the Cancer Vaccine Rally Back On?

Dow Jones
·
19 hours ago

AbbVie Targets Dry Eye Market Upside With New ABBV-444 Trial Update

TIPRANKS
·
19 hours ago

US Regulators Urge More Research on Testosterone Therapy for Women as Experts Debate Benefits, Risks

Reuters
·
19 hours ago

Niagen Bioscience Names Martin Hendrix Strategic Adviser for Corporate Strategy, M&A

Reuters
·
Yesterday

Goldman Sachs Adjusts Eli Lilly Price Target to $1,371 From $1,367, Maintains Buy Rating

MT Newswires Live
·
Yesterday